Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

172.21
Delayed Data
As of 3:59pm ET
 -0.74 / -0.43%
Today’s Change
95.14
Today|||52-Week Range
175.72
+52.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line8.9M15.4M14.9M37.4M
 
 
 
 
 
Depreciation1.6M1.5M1.7M2.5M
 
 
 
 
 
Total Other Cash Flow7.7M6.6M3.1M9.4M
 
 
 
 
 
Funds From Operations20.9M32.6M26.7M45.4M
 
 
 
 
 
Funds From/For Other Operating Expenses3.6M-1.5M-10.6M9.1M
 
 
 
 
 
Net Cash Flow - Operating Activities17.4M34.1M37.3M36.3M
 
 
 
 
 
 
InvestingIncrease In Investments-66.9M-43.5M-103.7M-74.0M
 
 
 
 
 
Decrease In Investments69.6M28.0M60.8M66.6M
 
 
 
 
 
Capital Expenditures-5.4M-13.6M-26.4M-9.8M
 
 
 
 
 
Net Cash Flow Investing-2.7M-29.1M-69.2M-17.2M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction-83.0K-181.0K-182.0K-184.0K
 
 
 
 
 
Net Proceeds Stock Sale3.8M2.5M3.3M3.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing2.6M964.0K7.4M0.00
 
 
 
 
Other Uses - Financing4.6M290.0K207.0K17.8M
 
 
 
 
 
Net Cash Flow - Financing1.7M3.0M10.4M-14.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash60.0K-1.7M-460.0K278.0K
 
 
 
 
 
 
Net Change In Cash16.4M8.0M-21.6M4.7M